No abstract available
MeSH terms
-
Antineoplastic Agents
-
Carcinoma, Transitional Cell / mortality
-
Carcinoma, Transitional Cell / pathology
-
Carcinoma, Transitional Cell / therapy*
-
Clinical Trials as Topic
-
Humans
-
Neoplasm Metastasis
-
Prognosis
-
Survival Rate
-
Urologic Neoplasms / mortality
-
Urologic Neoplasms / pathology
-
Urologic Neoplasms / therapy*